An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib+ radiation for newly-diagnosed glioblastoma (GBM) patients Article

Chakravarti, A, Seiferheld, W, Robins, HI et al. (2004). An update of phase I data from RTOG 0211: A phase I/II clinical study of gefitinib+ radiation for newly-diagnosed glioblastoma (GBM) patients . JOURNAL OF CLINICAL ONCOLOGY, 22(14_suppl), 1571-1571. 10.1200/jco.2004.22.90140.1571

cited authors

  • Chakravarti, A; Seiferheld, W; Robins, HI; Guha, A; Brachman, D; Curran, W; Choucair, A; Mehta, M

authors

publication date

  • July 15, 2004

published in

keywords

  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • 1571

end page

  • 1571

volume

  • 22

issue

  • 14_suppl